NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes

Sailesh Surapureddi1, Ritu Rana, Joyce A Goldstein

  • 1Laboratory of Toxicology and Pharmacology, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709, United States.

Pharmacological Research
|February 5, 2011
PubMed

Insights

Nuclear receptors pregnane X receptor (PXR) and hepatocyte nuclear factor 4 alpha (HNF4α) synergistically regulate drug-metabolizing enzymes. NCOA6 acts as a bridge, mediating this interaction for CYP2C9 but not CYP3A4.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • Cytochrome P450 enzymes, specifically CYP2C and CYP3A subfamilies, are crucial for metabolizing prescribed medications.
  • The expression of these enzymes is regulated by nuclear receptors, including hepatocyte nuclear factor 4 alpha (HNF4α) and rifampicin-activated pregnane X receptor (PXR).

Purpose of the Study:

  • To elucidate the mechanism of ligand-dependent synergistic cross-talk between PXR and HNF4α.
  • To investigate the role of NCOA6 in mediating the interaction between PXR and HNF4α in regulating CYP gene expression.

Main Methods:

  • Two-hybrid screening to identify interacting proteins.
  • GST pull-down and mammalian two-hybrid assays to confirm protein interactions.
  • Reporter assays to assess promoter activity.
  • NCOA6 silencing to evaluate its functional role.
  • Chromatin immunoprecipitation (ChIP) analysis to determine promoter binding.

Main Results:

  • NCOA6 was identified as an interacting protein for HNF4α and also interacts with PXR.
  • NCOA6 enhances the synergistic activation of CYP2C9 and CYP3A4 promoter activity by PXR and HNF4α.
  • Silencing NCOA6 abrogated the synergistic activation and induction of CYP2C9, but not CYP3A4, by PXR-HNF4α.
  • ChIP analysis showed NCOA6 bridges PXR and HNF4α binding sites on the CYP2C9 promoter.

Conclusions:

  • NCOA6 is essential for the synergistic activation of CYP2C9 gene expression by HNF4α and PXR.
  • NCOA6 differentially regulates CYP2C9 and CYP3A4 gene expression, despite both being regulated by the same nuclear receptors.

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...